+44 1223 790975Study, Design, Analysis of Clinical Trails
Study, Design, Analysis of Clinical Trails
Most countries have adopted the good clinical practice (GCP) principles as laws and regulations for approving clinical trials which are conducted to test new methods to prevent, detect, and treat disease or drug development. Most regulatory agencies such as the United State Food and Drug Administration (FDA) indicate that only adequate and well-controlled clinical trials can provide substantial evidence of safety and effectiveness of the test treatment under investigation.
Study, Design and Analysis of Clinical Trials provides complete, comprehensive, and expanded coverage of recent health treatments and interventions, In this context Drug Designing: Open Access Journal is coming up with a special issue titled: “Study, Design, Analysis of Clinical Trails” which has been edited by Dr. Shein-Chung Chow.
Dr. Shein-Chung Chow, PhD, is Professor in the Department of Biostatistics and Bioinformatics at Duke University School of Medicine, United States. He has authored multiple articles and books on clinical trials and been involved in clinical trials as a biostatistician.
We warmly and enthusiastically invite the eminent researchers to take part in this special issue to enhance recent Study, Design and Analysis of Clinical Trials.
We encourage submission of research articles, review articles, short communication, mini-review, case reports, editorial, etc. through email at ddo[at]jpeerreview[dot]org
Submissions are accepted from November 20th, 2020 till December 22nd, 2020